Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Harvard Business School
Citi
Daiichi Sankyo
Argus Health
Merck

Generated: May 23, 2019

DrugPatentWatch Database Preview

SUPPRELIN LA Drug Profile

« Back to Dashboard

When do Supprelin La patents expire, and what generic alternatives are available?

Supprelin La is a drug marketed by Endo Pharm and is included in one NDA. There is one patent protecting this drug.

This drug has three patent family members in three countries.

The generic ingredient in SUPPRELIN LA is histrelin acetate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the histrelin acetate profile page.

Drug patent expirations by year for SUPPRELIN LA
Synonyms for SUPPRELIN LA
((ImBl)-D-His(sub 6),Pro(sub 9)-NEt)LHRH
[(im-Bzl)-D-His(6),Pro(9)-NEt]-gonadotropin releasing hormone
220810-26-4
5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-1-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-N(sup tau)-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-N(tau)-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
712H828
76712-82-8
AKOS030573448
AN-36908
BRN 4290557
C15H18N2O.CH4
C66H86N18O12
CHEBI:5739
CHEMBL1201255
D02369
DTXSID50227543
FT-0630849
GTPL3884
H50H3S3W74
histrelin
Histrelin (USAN/INN)
Histrelin [USAN:INN]
Histrelin acetate
Histrelina
Histrelina [Spanish]
Histreline
Histreline [French]
Histrelinum
Histrelinum [Latin]
HSDB 7657
K321
L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-N(im)-benzyl-histidyl-L-leucyl-L-arginyl-L-proline ethylamide
LS-88250
Luteinizing hormone-releasing factor (pig), 6-(1-(phenylmethyl)-D-histidine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-
Luteinizing hormone-releasing factor, 6-(1-(phenylmethyl)-D-histidine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-
NCGC00181758-01
ORF 17070
ORF-17070
RWJ 17070
RWJ-17070
SCHEMBL17881
SCHEMBL19409305
SCHEMBL19712198
Supprelin
UNII-H50H3S3W74
Vantaas

US Patents and Regulatory Information for SUPPRELIN LA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharm SUPPRELIN LA histrelin acetate IMPLANT;SUBCUTANEOUS 022058-001 May 3, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for SUPPRELIN LA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Pharm SUPPRELIN LA histrelin acetate IMPLANT;SUBCUTANEOUS 022058-001 May 3, 2007 ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharm SUPPRELIN LA histrelin acetate IMPLANT;SUBCUTANEOUS 022058-001 May 3, 2007 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Merck
Boehringer Ingelheim
US Department of Justice
UBS
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.